Total Payments
$9.5M
2024 Payments
$1.5M
Companies
8
Transactions
62
Medicare Patients
8,716
Medicare Billing
$7.8M
Payment Breakdown by Category
Royalty/License$9.5M (99.8%)
Consulting$14,112 (0.1%)
Other$3,500 (0.0%)
Food & Beverage$1,496 (0.0%)
Travel$1,281 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $9.5M | 35 | 99.8% |
| Consulting Fee | $14,112 | 4 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 1 | 0.0% |
| Food and Beverage | $1,496 | 17 | 0.0% |
| Travel and Lodging | $1,281 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $7.8M | 39 | $0 (2024) |
| Alcon Laboratories Inc | $1.5M | 10 | $0 (2018) |
| Alcon Research LLC | $284,591 | 6 | $0 (2022) |
| Heidelberg Engineering, Inc. | $247.19 | 3 | $0 (2018) |
| The Cameron-Ehlen Group, Inc. | $157.41 | 1 | $0 (2017) |
| Dutch Ophthalmic, USA | $145.61 | 1 | $0 (2023) |
| Allergan Inc. | $47.87 | 1 | $0 (2018) |
| Alimera Sciences, Inc. | $38.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1.5M | 7 | Alcon Vision LLC ($1.5M) |
| 2023 | $1.3M | 9 | Alcon Vision LLC ($1.3M) |
| 2022 | $1.3M | 9 | Alcon Vision LLC ($1.2M) |
| 2021 | $1.2M | 7 | Alcon Vision LLC ($933,645) |
| 2020 | $1.1M | 9 | Alcon Vision LLC ($1.0M) |
| 2019 | $1.8M | 6 | Alcon Vision LLC ($1.8M) |
| 2018 | $767,831 | 8 | Alcon Laboratories Inc ($767,536) |
| 2017 | $689,934 | 7 | Alcon Laboratories Inc ($689,777) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $362,536.63 | General |
| 08/29/2024 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $442,222.81 | General |
| 05/29/2024 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $336,501.00 | General |
| 03/07/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $35.92 | General |
| Category: Ophthalmology | ||||||
| 03/05/2024 | Alcon Vision LLC | FINESSE SHARKSKIN (Device) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Ophthalmology | ||||||
| 03/04/2024 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $229.30 | General |
| Category: Ophthalmology | ||||||
| 02/21/2024 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $336,327.75 | General |
| 11/29/2023 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $339,344.50 | General |
| 11/15/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $145.61 | General |
| Category: Ophthalmology | ||||||
| 10/13/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $38.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/29/2023 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $335,960.63 | General |
| 08/10/2023 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Ophthalmology | ||||||
| 05/15/2023 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $324,068.25 | General |
| 03/06/2023 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $108.17 | General |
| Category: Ophthalmology | ||||||
| 03/06/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Ophthalmology | ||||||
| 02/10/2023 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $327,120.75 | General |
| 11/08/2022 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $322,140.50 | General |
| 10/07/2022 | Alcon Research LLC | FINESSE SHARKSKIN (Device) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Ophthalmology | ||||||
| 09/05/2022 | Alcon Vision LLC | FINESSE SHARKSKIN (Device) | Travel and Lodging | In-kind items and services | $183.55 | General |
| Category: Ophthalmology | ||||||
| 09/05/2022 | Alcon Vision LLC | FINESSE SHARKSKIN (Device) | Travel and Lodging | In-kind items and services | $180.46 | General |
| Category: Ophthalmology | ||||||
| 08/08/2022 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $322,022.25 | General |
| 08/05/2022 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Ophthalmology | ||||||
| 07/14/2022 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Ophthalmology | ||||||
| 05/11/2022 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $289,832.35 | General |
| 02/21/2022 | Alcon Vision LLC | — | Royalty or License | Cash or cash equivalent | $314,656.38 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,456 | 11,778 | $6.6M | $1.5M |
| 2022 | 12 | 1,971 | 7,728 | $5.1M | $1.9M |
| 2021 | 15 | 2,332 | 9,241 | $3.6M | $2.2M |
| 2020 | 13 | 2,957 | 10,246 | $3.8M | $2.3M |
Total Patients
8,716
Total Services
38,993
Medicare Billing
$7.8M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 122 | 1,300 | $3.8M | $899,111 | 23.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 24 | 6,360 | $798,180 | $184,826 | 23.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 30 | 680 | $574,600 | $123,728 | 21.5% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 23 | 430 | $240,800 | $93,399 | 38.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 230 | 893 | $637,568 | $86,614 | 13.6% |
| 92134 | Imaging of retina | Office | 2023 | 436 | 1,251 | $205,164 | $36,940 | 18.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 205 | 341 | $121,396 | $22,488 | 18.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 215 | 238 | $119,952 | $21,932 | 18.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 56 | 166 | $41,500 | $8,993 | 21.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 45 | 45 | $21,195 | $4,800 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $20,181 | $3,685 | 18.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 26 | 26 | $15,548 | $2,664 | 17.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 13 | 17 | $3,332 | $662.15 | 19.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 157 | 1,788 | $3.1M | $1.3M | 41.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 57 | 1,512 | $756,000 | $332,649 | 44.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 319 | 1,270 | $569,928 | $123,698 | 21.7% |
| 92134 | Imaging of retina | Office | 2022 | 597 | 1,733 | $220,069 | $51,910 | 23.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 308 | 565 | $156,428 | $37,056 | 23.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 119 | 419 | $62,850 | $22,456 | 35.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 206 | 224 | $87,584 | $19,085 | 21.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 75 | 79 | $28,914 | $7,697 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $28,785 | $6,993 | 24.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 45 | 45 | $20,925 | $4,858 | 23.2% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2022 | 17 | 19 | $14,991 | $3,749 | 25.0% |
| 92250 | Photography of the retina | Office | 2022 | 14 | 17 | $2,057 | $400.86 | 19.5% |
About Dr. Edwin Ryan, MD
Dr. Edwin Ryan, MD is a Ophthalmology healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093703167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edwin Ryan, MD has received a total of $9.5M in payments from pharmaceutical and medical device companies, with $1.5M received in 2024. These payments were reported across 62 transactions from 8 companies. The most common payment nature is "Royalty or License" ($9.5M).
As a Medicare-enrolled provider, Ryan has provided services to 8,716 Medicare beneficiaries, totaling 38,993 services with total Medicare billing of $7.8M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Minneapolis, MN
- Active Since 10/12/2005
- Last Updated 11/08/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1093703167
Products in Payments
- FINESSE SHARKSKIN (Device) $3,188
- NGENUITY (Device) $486.12
- Constellation (Device) $284.97
- Spectralis (Device) $247.19
- D.O.R.C. Instruments (Device) $157.41
- EVA, combined machine (Device) $145.61
- OZURDEX (Drug) $47.87
- ILUVIEN (Drug) $38.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Minneapolis
Dr. Andrew Harrison, M.d, M.D
Ophthalmology — Payments: $198,088
Ophthalmology $198,088
David Hardten, M.d, M.D
Ophthalmology — Payments: $161,310
Ophthalmology $161,310
Dr. Sandra Rocio Montezuma, M.d, M.D
Ophthalmology — Payments: $55,602
Ophthalmology $55,602
Sundeep Dev, Md, MD
Ophthalmology — Payments: $19,059
Ophthalmology $19,059
Robert Mittra, Md, MD
Ophthalmology — Payments: $17,494
Ophthalmology $17,494
Dr. Ali Mokhtarzadeh, M.d, M.D
Ophthalmology — Payments: $6,738
Ophthalmology $6,738